Organon (OGN) Gains from Investment Securities (2021 - 2025)
Organon (OGN) has 5 years of Gains from Investment Securities data on record, last reported at $1.0 million in Q4 2025.
- For Q4 2025, Gains from Investment Securities fell 97.5% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $15.0 million, down 31.82%, while the annual FY2025 figure was $15.0 million, 115.89% up from the prior year.
- Gains from Investment Securities reached $1.0 million in Q4 2025 per OGN's latest filing, roughly flat from $1.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $41.0 million in Q4 2023 and bottomed at -$37.0 million in Q3 2023.
- Average Gains from Investment Securities over 5 years is $2.1 million, with a median of $1.0 million recorded in 2023.
- The widest YoY moves for Gains from Investment Securities: up 566.67% in 2022, down 1166.67% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at -$12.0 million in 2021, then skyrocketed by 283.33% to $22.0 million in 2022, then surged by 86.36% to $41.0 million in 2023, then decreased by 2.44% to $40.0 million in 2024, then tumbled by 97.5% to $1.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $33.0 million in Q2 2025.